Nicholas M. Dean
Nessuna posizione attualmente
Profilo
Dr. Nicholas M.
Dean is a Director & Chief Scientific Officer at Microlin Bio, Inc. He is on the Board of Directors at Microlin Bio, Inc.
Dr. Dean was previously employed as a Director & Chief Scientific Officer by Excaliard Pharmaceuticals, Inc. and Vice President-Functional Genomics & Oncology by Isis Pharmaceuticals, Inc.
He received his undergraduate degree from The University of Wales and a doctorate degree from The University of Wales.
Precedenti posizioni note di Nicholas M. Dean
| Società | Posizione | Fine |
|---|---|---|
Excaliard Pharmaceuticals, Inc.
 Excaliard Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Excaliard Pharmaceuticals, Inc. manufactures, develops therapeutics for the treatment of scarring and fibrotic disorders. The company was founded by John Gordon Foulkes and Nicholas M. Dean in 2006 and is headquartered in New York, NY. | Founder | 01/03/2012 |
Microlin Bio, Inc. /Old/
 Microlin Bio, Inc. /Old/ Medical SpecialtiesHealth Technology Microlin Bio, Inc. is a pre-clinical stage biopharmaceutical company. It focuses on the development of miR-based diagnostics and therapeutics, including both antimiRs and miR mimics, to diagnose and treat cancer. The company was founded by Joseph Hernandez on July 30, 2013 and is headquartered in New York, NY. | Chief Tech/Sci/R&D Officer | - |
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formazione di Nicholas M. Dean
| The University of Wales | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| IONIS PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Microlin Bio, Inc. /Old/
Microlin Bio, Inc. /Old/ Medical SpecialtiesHealth Technology Microlin Bio, Inc. is a pre-clinical stage biopharmaceutical company. It focuses on the development of miR-based diagnostics and therapeutics, including both antimiRs and miR mimics, to diagnose and treat cancer. The company was founded by Joseph Hernandez on July 30, 2013 and is headquartered in New York, NY. | Health Technology |
Excaliard Pharmaceuticals, Inc.
Excaliard Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Excaliard Pharmaceuticals, Inc. manufactures, develops therapeutics for the treatment of scarring and fibrotic disorders. The company was founded by John Gordon Foulkes and Nicholas M. Dean in 2006 and is headquartered in New York, NY. | Health Technology |
- Borsa valori
- Insiders
- Nicholas M. Dean
